- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mangalam Drugs And Organics Limited — Board Meeting, 15-01-2026: Outcome of Board Meeting
15-01-2026 | 05:43 pm
15-01-2026 | 05:43 pm
Mangalam Drugs (MANGALAM) announced a Q3 consolidated net loss of ₹9.84 Cr, with sales at ₹58.38 Cr. The CFO and Company Secretary both resigned. A merger scheme's final hearing is scheduled for March 10, 2026.
No comments yet. Be the first to comment!